|
|
|
| Webinar: Bacterial Retention Testing Explained: Demonstrating Filter Performance For Your Product | How do you demonstrate that sterilizing filters perform as intended? Join Alcami to explore bacterial retention testing, including the role of Brevundimonas diminuta, the impact of product and process conditions, and how filter integrity testing supports validation. Gain practical insights into planning bacterial challenge studies, interpreting results, and aligning testing strategies with product requirements and sterile manufacturing needs. Click here to learn more. |
|
|
|
|
|
| Harness High-Quality PBPK Modeling To Enhance Clinical Readiness | Article | By Deanna Mudie, Ph.D., and John DiBella, Lonza | Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties. |
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | Subpar customer service at CDMOs is no longer something sponsors tolerate; there’s enough competition where they can move on. The other side of the coin is how difficult sponsors sink to the bottom of CDMO priorities; providers also have options. Here's an analysis less about technical components of outsourcing, and more on mutual satisfactions from working together to fulfill contractual arrangements and missions. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| Formulation And Process Challenges For A Needle-Shaped API | Case Study | By Alexander Schmid, Nadine Straede, and Jennifer Look, Rottendorf Pharma | Managing challenging active pharmaceutical ingredient crystal structures and choosing dry granulation over wet granulation requires strategic processing choices. |
|
|
| Navigating High-Potency OSD Manufacturing | Article | Recipharm | Learn how containment strategy, process design, and early risk‑based decisions influence operator protection, compliance, and long‑term manufacturing success as potency levels continue to rise. |
|
|
|
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
